Pap smear: Clinical Trials

9 trials of Pap smear, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 not yet recruiting, 1 terminated. 3 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Not yet recruiting 1, Terminated 1
Phase 11Completed 1
Phase 31Unknown 1

Follow Pap smear: new trials by email Literature Review of Pap smear trials Research Report on Pap smear

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity
Human papillomavirus Self-collection, Usual Care - Uterine Cervical Neoplasms, HPV Testing
Not applicableNot yet recruitingUniversity of Arizona1002026-08-012026-05-29
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
Vaginal specimens for HPV test will be collected by participants themselves using flocked swabs after explanations by co-investigators. - Cervical Cancer Screening, HPV Infections
CompletedUniversity Hospital, Geneva5002024-06-012026-01-21
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Uterine lavage, or a wash of the womb, Blood sample, Pap smear - Ovarian Neoplasms, Ovarian Epithelial Carcinoma
RecruitingMassachusetts General Hospital2502020-04-132025-09-16
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Biospecimen Collection, Liquid Biopsy, Pap Smear - Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma
RecruitingM.D. Anderson Cancer Center10002019-06-182026-10-07
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
Biospecimen Collection, Laboratory Biomarker Analysis, Lavage - High Grade Ovarian Serous Adenocarcinoma, Stage III Ovarian Cancer AJCC v8
Not applicableTerminatedUniversity of Washington522018-11-162024-01-17
The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection
FRD, Cytology, HPV testing - Cervical Intraepithelial Neoplasia Grade 2/3
Phase 3UnknownGY Highland Biotech LLC2002017-12-072017-12-08
chemQbiosciences:Manual Liquid Based Cytology
Pap smear - Cervical Dysplasia, Cervical Cancer
CompletedUniversity of North Carolina, Chapel Hill762013-05-012013-12-04
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
Nelfinavir, Cisplatin, Pelvic External Beam Radiation Therapy - Cervical Cancer
Phase 1CompletedUniversity of Miami82012-01-012015-06-03
Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia
HPV test, COLPOSCOPY, cytology - Cervical Abnormalities, Cervical Intraepithelial Neoplasia Grade 2/3
Not applicableCompletedUniversidad de Antioquia26612011-01-012019-09-19

Conditions studied

Uterine Cervical Neoplasms (4)  ·  Uterine Cervical Dysplasia (3)  ·  Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ovarian Diseases (1)  ·  Papillomavirus Infections (1)  ·  Uterine Neoplasms (1)

Sponsors

GY Highland Biotech LLC (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Universidad de Antioquia (1)  ·  University Hospital, Geneva (1)  ·  University of Arizona (1)  ·  University of Miami (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Washington (1)

Countries

United States (7)  ·  Cameroon (1)  ·  Colombia (1)

Top investigators

Alejandra Botero, MSc (1)  ·  Armando Baena, MSc, PhD (1)  ·  Astrid Bedoya, MSc (1)  ·  Barbara S. Norquist (1)  ·  Calatina Villa, BSc (1)  ·  Carlos A Buitrago, MD, Esp (1)  ·  Christos Patriotis, PhD (1)  ·  Dan Theodorescu, MD, PhD (1)  ·  Daron G Ferris, MD (1)  ·  Gloria I Sanchez, MSc, PhD (1)  ·  Guadalupe Posada, MD, Esp (1)  ·  J. Matthew Pearson, MD (1)  ·  Juan C Ochoa, MD, Esp (1)  ·  Lisa Rahangdale, MD, MPH (1)  ·  Luis J Gomez, MD, Esp (1)

Results publications

PMID 32049551, PMID 32617889, PMID 38176019

NIH funding

P30CA023074 (1), U01CA152990 (1), U2CCA271871 (1)